Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling - Wikidata - wikimedia - TriplyDB

Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling

Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling

http://www.wikidata.org/entity/Q28259810

about

Mal connects TLR2 to PI3Kinase activation and phagocyte polarization Toll-like receptor cascade and gene polymorphism in host-pathogen interaction in Lyme disease Interferon induction by RNA viruses and antagonism by viral pathogens Postnatal TLR2 activation impairs learning and memory in adulthood.The Role of Toll-Like Receptors in Hematopoietic Malignancies International Union of Basic and Clinical Pharmacology. XCVI. Pattern recognition receptors in health and disease Src homology 3-interacting domain of Rv1917c of Mycobacterium tuberculosis induces selective maturation of human dendritic cells by regulating PI3K-MAPK-NF-kappaB signaling and drives Th2 immune responses Toll-like receptor 2 (TLR2) plays a role in controlling cutaneous leishmaniasis in vivo, but does not require activation by parasite lipophosphoglycan Comparison of Cellular Uptake and Inflammatory Response via Toll-Like Receptor 4 to Lipopolysaccharide and Titanium Dioxide Nanoparticles The effect of oxidized phospholipids on phenotypic polarization and function of macrophages.Identification of Adjuvantic Activity of Amphotericin B in a Novel, Multiplexed, Poly-TLR/NLR High-Throughput Screen.Natural killer T cells activated by a lipopeptidophosphoglycan from Entamoeba histolytica are critically important to control amebic liver abscess Effects of the TLR2 agonists MALP-2 and Pam3Cys in isolated mouse lungs CD47 and TLR-2 cross-talk regulates neutrophil transmigration.Toll-Like Receptors and Cancer: MYD88 Mutation and Inflammation.Toll-like receptor transcriptome in the HPV-positive cervical cancer microenvironment Muramyl dipeptide synergizes with Staphylococcus aureus lipoteichoic acid to recruit neutrophils in the mammary gland and to stimulate mammary epithelial cells.FcεR1-mediated mast cell reactivity is amplified through prolonged Toll-like receptor-ligand treatment.Toll-like receptor 2 agonists inhibit human fibrocyte differentiation.A novel inflammatory pathway mediating rapid hepcidin-independent hypoferremia.Mycobacterium tuberculosis lipoproteins directly regulate human memory CD4(+) T cell activation via Toll-like receptors 1 and 2.FSL-1, a Toll-like Receptor 2/6 Agonist, Induces Expression of Interleukin-1α in the Presence of 27-hydroxycholesterol.Skin fibroblasts from individuals with Chediak-Higashi Syndrome (CHS) exhibit hyposensitive immunogenic response.Extracellular vesicles modulate host-microbe responses by altering TLR2 activity and phagocytosis.Role of phosphoinositide 3-kinase-Akt signaling pathway in the age-related cytokine dysregulation in splenic macrophages stimulated via TLR-2 or TLR-4 receptors Toll-like receptors in secondary obstructive cholangiopathy.Toll-like receptor polymorphisms and tuberculosis susceptibility: A comprehensive meta-analysis.Activation of TLR2 and TLR6 by Dengue NS1 Protein and Its Implications in the Immunopathogenesis of Dengue Virus Infection.The role of innate immune signaling in the pathogenesis of atopic dermatitis and consequences for treatments.The role of airway epithelial cells in response to mycobacteria infection.The Role of TLR2 in Infection and Immunity The Poly-γ-d-Glutamic Acid Capsule Surrogate of the Bacillus anthracis Capsule Is a Novel Toll-Like Receptor 2 Agonist.A Modified Glycosaminoglycan, GM-0111, Inhibits Molecular Signaling Involved in Periodontitis.Lipoproteins/peptides are sepsis-inducing toxins from bacteria that can be neutralized by synthetic anti-endotoxin peptides.ERK5 protein promotes, whereas MEK1 protein differentially regulates, the Toll-like receptor 2 protein-dependent activation of human endothelial cells and monocytes.Trial Watch: Experimental Toll-like receptor agonists for cancer therapy Intestinal Serotonin Transporter Inhibition by Toll-Like Receptor 2 Activation. A Feedback Modulation Nonbilayer Phospholipid Arrangements Are Toll-Like Receptor-2/6 and TLR-4 Agonists and Trigger Inflammation in a Mouse Model Resembling Human Lupus.HBD-3 induces NK cell activation, IFN-γ secretion and mDC dependent cytolytic function Multiple Signaling Molecules are Involved in Expression of CCL2 and IL-1β in Response to FSL-1, a Toll-Like Receptor 6 Agonist, in Macrophages

P2860

Q24310427-15BA4AEA-4C0A-4611-922B-906702F96A49 Q26744045-1CCA5266-CEA2-4814-B28E-01BC07FA38CA Q26860007-05167B40-FE05-490A-A46E-74DB688F655D Q27331559-16491DB7-5AAB-4786-A207-CB8681E4A210 Q28077740-2DA709A1-EF18-46EC-8FD1-8B3EFB149C72 Q28081406-9B4A85E3-5773-478C-973A-C2721034134F Q28487315-AED2EF29-6F0A-4B13-A9C3-07A959A39EC4 Q28822416-CF2FC739-EAE8-4ED3-A8D6-66866BF81966 Q29248679-953B9D2E-EC7B-44C0-BB00-F2466CBB19A7 Q30268532-BFBA6C18-3860-4E0F-A5F0-BA11297FC28F Q30388683-5380D19C-F0DF-4821-B3FD-14097D1ED04C Q33444653-5FE66320-07B9-4E28-83E8-EF664C5BB0A9 Q33761304-C416D463-1FE9-4BFB-9233-426801E0E2DB Q33853953-EF59D709-2FC4-43A7-9355-DB0F0CEDB5CB Q33978723-F0EC5337-7062-4D14-9DC2-23DD99E06273 Q34052237-8E3C21EB-D912-4A51-B7F9-E0C08DBF2280 Q34289860-FBDA8129-D704-44C7-B0AC-D9DEA52D2605 Q34391700-E9E78910-E282-4BEF-91BE-CDDE4B2B6123 Q34408050-7DC6B6BB-021D-4585-88A2-CBA23E8F7C2D Q34461765-6B79DCDE-7316-43BC-B346-57988F9AEC4C Q34529474-ED69E888-534F-49F4-96B7-55238DF625AC Q34974190-2B6FAEFE-4251-49E2-95F8-9F471DCCB421 Q34976606-153B94F9-542C-44BE-BEF6-8F0AFCBE8B3E Q35106699-C8691B5D-3A08-4CB4-9BB0-2B5F2052463D Q35162960-AC30E508-BE26-42AE-BEE3-DF9E67D988B5 Q35495496-ABD54B60-1F0D-4E23-B519-2F3AEF460D7E Q35602729-12AFDC87-1D98-4DF6-A4FE-4840C631C2F4 Q35727211-B1079354-01FC-4611-B694-824CFF68F418 Q35842929-18789E5C-96D0-4152-ABCE-FF177A3EEB6C Q35915391-52E422C1-8773-43FE-ABD3-682F4660D92E Q35927566-010A4FF6-A762-4E44-AC95-59154D9FFCFB Q36053487-C13BDCBB-4DAF-4FD8-B954-F88DB127CD69 Q36053859-8A6181F3-A779-4CC5-ADB3-B2F45F52F2D9 Q36099284-A976F971-D21B-4D63-82D2-E6CA2C9754E7 Q36137308-71F525A7-2780-4F6C-9FB3-4739DA2CC832 Q36194849-8E4C3AA7-96F6-4180-9C3B-9C4ACFC72D41 Q36235708-E577FC1B-26FA-4C23-99DE-8C661C341D81 Q36237416-78FF172E-97FD-4879-A64B-E7BFB8BE22E1 Q36381044-7CFE149C-61E4-4274-B607-81C1946380AB Q36479130-F2E5E8F8-5EFA-4229-BBC5-B7CFF633E3A6

P2860

Heterodimerization of TLR2 with TLR1 or TLR6 expands the ligand spectrum but does not lead to differential signaling

http://www.wikidata.org/entity/Q28259810

description

2008 nî lūn-bûn

@nan

2008 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի մարտին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Heterodimerization of TLR2 wit ...... lead to differential signaling

@ast

Heterodimerization of TLR2 wit ...... lead to differential signaling

@en

Heterodimerization of TLR2 wit ...... lead to differential signaling

@nl

type

label

Heterodimerization of TLR2 wit ...... lead to differential signaling

@ast

Heterodimerization of TLR2 wit ...... lead to differential signaling

@en

Heterodimerization of TLR2 wit ...... lead to differential signaling

@nl

prefLabel

Heterodimerization of TLR2 wit ...... lead to differential signaling

@ast

Heterodimerization of TLR2 wit ...... lead to differential signaling

@en

Heterodimerization of TLR2 wit ...... lead to differential signaling

@nl

P1433

Q28259810-7DAEA3C9-6999-4C5E-9951-3414BFF07AD0

P1476

Q28259810-FBD61504-F467-4496-B836-4AE20D04D569

P2093

Q28259810-102F41C5-1F9F-4008-A60D-D62EA65C1169

Q28259810-59210164-B294-4789-BD19-BF98E80767DA

Q28259810-6A0A74F4-C153-4DAB-9330-CE44DC25FBE2

Q28259810-8B8B0A01-B235-46B8-A62A-8889BCC52C4B

Q28259810-8FA85520-A9CD-4AA2-B9AF-74BB5381E237

Q28259810-94E37167-C9CC-44ED-87C7-03009441B92A

Q28259810-B934D812-D4CA-4008-8D9C-799628FEC2C3

Q28259810-BBC92344-B664-4198-9AA9-7D9067B5F44A

Q28259810-C6BAE0E8-A445-4759-A5E5-EF5E5A1290D6

P304

Q28259810-04F10376-A190-46BC-BE04-5226BE44ECF6

P31

Q28259810-63FA2532-66C1-4BFD-B525-7B6DE38ADC9C

P3181

Q28259810-E6DE6962-D0C9-4BB0-B5D9-460BA5506E6D

P356

Q28259810-7C114B3E-1D12-4EEC-8702-3812938CAF92

P407

Q28259810-A029FB0E-B338-4EAD-AA40-130EDE90391B

P433

Q28259810-2E6EB966-E553-4B95-AD4D-ECDE3951FED6

P478

Q28259810-5376768A-120A-4727-A4FB-17F41D14EB6C

P50

Q28259810-211CBE30-38CC-4F7B-BCBB-8C31C7463E96

Q28259810-AE1DB530-4A0D-4ABB-B906-E8558A4B37F0

P577

Q28259810-37D08ACB-0672-4CC7-8070-CF06FC5C2248

P5875

Q28259810-71783075-BBAE-449B-81FB-B1024F2A3BE2

P698

Q28259810-6CE695D7-4A71-4791-865C-F8CE12CC538E

P921

Q28259810-921CA306-AF28-4CBE-8C52-A773C1DC8772

P3181

P356

P1433

Journal of Leukocyte Biology

P1476

Heterodimerization of TLR2 wit ...... lead to differential signaling

@en

P2093

Artur J Ulmer

http://www.w3.org/2001/XMLSchema#string

Günther Jung

http://www.w3.org/2001/XMLSchema#string

Holger Heine

http://www.w3.org/2001/XMLSchema#string

Jörg Mages

http://www.w3.org/2001/XMLSchema#string

Karl-Heinz Wiesmüller

http://www.w3.org/2001/XMLSchema#string

Katja Farhat

http://www.w3.org/2001/XMLSchema#string

Kristina Röschmann

http://www.w3.org/2001/XMLSchema#string

Sabine Riekenberg

http://www.w3.org/2001/XMLSchema#string

Ute Buwitt-Beckmann

http://www.w3.org/2001/XMLSchema#string

P304

692-701

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

731071

http://www.w3.org/2001/XMLSchema#string

P356

10.1189/JLB.0807586

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

83

http://www.w3.org/2001/XMLSchema#string

P50

P577

2008-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5792649

http://www.w3.org/2001/XMLSchema#string

P698

18056480

http://www.w3.org/2001/XMLSchema#string

P921

Toll-like receptor